HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFκB pathway dysregulation-Reference-Cited by-同舟云学术

HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFκB pathway dysregulation

Published:2014-01-22 Issue:3 Volume:137 Page:819-833
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Träger Ulrike,Andre Ralph,Lahiri Nayana,Magnusson-Lind Anna,Weiss Andreas,Grueninger Stephan,McKinnon Chris,Sirinathsinghji Eva,Kahlon Shira,Pfister Edith L.,Moser Roger,Hummerich Holger,Antoniou Michael,Bates Gillian P.,Luthi-Carter Ruth,Lowdell Mark W.,Björkqvist Maria,Ostroff Gary R.,Aronin Neil,Tabrizi Sarah J.

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/137/3/819/13797635/awt355.pdf

Reference63 articles.

1. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life;Ajami;Nat Neurosci,2007

2. TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages;Alciato;J Leukoc Biol,2010

3. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40;Alderson;J Exp Med,1993

4. Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: association with pathology;Anderson;Exp Neurol,1994

5. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease;Andrew;Nat Genet,1993

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New opportunities for antioxidants in amelioration of neurodegenerative diseases;Mechanisms of Ageing and Development;2024-10

2. Identification of molecular targets and small drug candidates for Huntington's disease via bioinformatics and a network‐based screening approach;Journal of Cellular and Molecular Medicine;2024-08

3. Immunobiology and Immunotherapies in Huntington's Disease;Advances in Diagnostics and Immunotherapeutics for Neurodegenerative Diseases;2024-07-28

4. Gut Microbiota as a Modifier of Huntington’s Disease Pathogenesis;Journal of Huntington's Disease;2024-07-02

5. The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions;Frontiers in Immunology;2024-06-24